ATTENTION CYTK SHAREHOLDERS: Investors who lost money on Cytokinetics, Incorporated are urged to contact Levi & Korsinsky about an ongoing investigation

NEW YORK, NY / ACCESS Newswire / July 8, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) concerning possible violations of federal securities laws. BioPharma Dive published a report on Cytokinetics on May 2, 2025, and stated that, "The Food and Drug Administration has […]

Cochlear Launches World’s First and Only Smart Cochlear Implant System

— Upgradeable Firmware: The Cochlear™ Nucleus®Nexa™ System features upgradeable firmware on the implant – an industry first, allowing recipients to access future innovation through firmware updates. — Smallest Sound Processor: The new Nucleus 8 Nexa Sound Processor, with the new Power Compact rechargeable battery, is the smallest sound processor with all day battery life# on

ReserveOne Sets Out to Build the Digital Reserve of the Future

(NasdaqGM:MBAVU),(NasdaqGM:MBAV),(NasdaqGM:MBAVW), NEW YORK, July 08, 2025 (GLOBE NEWSWIRE) — ReserveOne Inc. (“ReserveOne”), a newly formed, first-of-its-kind digital asset management firm inspired by the proposed U.S. Strategic Bitcoin Reserve and Digital Asset Stockpile, today announced it has entered into a definitive business combination agreement with M3-Brigade Acquisition V Corp. (NASDAQ: MBAVU, MBAV, MBAVW) (“M3-Brigade”), a special

POET Technologies Announces Appointment of Sohail Khan as Director

(TSX-V:PTK),(NASDAQ:POET), TORONTO, July 08, 2025 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company“) (TSX Venture: PTK; NASDAQ: POET), the designer and developer of the POET Optical Interposer(TM), Photonic Integrated Circuits (PICs) and light sources for the data center, tele-communication and artificial intelligence markets, today announced the appointment of Sohail Khan as director and

Lost Money on DoubleVerify Holdings, Inc. (DV)? Contact Levi & Korsinsky Before July 21, 2025 to Join Class Action

NEW YORK, NY / ACCESS Newswire / July 8, 2025 / If you suffered a loss on your DoubleVerify Holdings, Inc. (NYSE:DV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/doubleverify-holdings-inc-lawsuit-submission-form-2?prid=155912&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or

Class Action Lawsuit Filed: Red Cat Holdings, Inc. (RCAT) – Join by July 22, 2025 – Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / July 8, 2025 / If you suffered a loss on your Red Cat Holdings, Inc. (NASDAQ:RCAT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/red-cat-holdings-inc-lawsuit-submission-form?prid=155913&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

Jeffs’ Brands Announces Closing of Acquisition Transaction: Fort Technology Inc. Expected to Resume Trading on TSX Venture Exchange

(NASDAQ:JFBR),(NASDAQ:JFBRW), Jeffs' Brands' equity stake in the merged company is 75.02% and may increase to up to 83.29% contingent upon meeting certain pre-determined milestones Tel Aviv, Israel, July 08, 2025 (GLOBE NEWSWIRE) — Jeffs' Brands Ltd (“Jeffs' Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace, today announced

Crescent Biopharma Appoints Jan Pinkas, Ph.D., as Chief Scientific Officer

(NASDAQ:CBIO), Seasoned Leader Brings Deep Experience in Oncology Drug Development as Company Advances Portfolio of Next Generation Therapeutics for Solid Tumors WALTHAM, Mass., July 08, 2025 (GLOBE NEWSWIRE) — Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a biotechnology company dedicated to rapidly advancing the next wave of therapies for cancer patients, today announced

Stallion Uranium Enters into Technology Data Acquisition Agreement

(TSX-V:STUD),(Boerse Frankfurt – Freiverkehr:HM40.F),(OTC US:STLNF),(Other OTC:STLNF),(Frankfurt:FE0), VANCOUVER, British Columbia, July 08, 2025 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion“) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to announce that, it has entered into a technology data acquisition agreement (the “Agreement“) dated April 24th, 2025, amongst the Company and Matthew J. Mason

Scroll to Top